Loading data for CPHI — first visit, this takes a few seconds.
China Pharma Holdings, Inc. (CPHI)
NYSE American: CPHI
· Real-Time Price · USD
0.84
+0.02 (2.44%)
At close: Sep 11, 2026, 8:00 PM
0.77
+1.26%
After-hours: 7:28 PM
The price, the headline numbers and the latest news, in one place.
China Pharma Holdings, Inc. (CPHI) Stock Price, Analysis & Data
No data available
| Bid | 0.83 |
| Market Cap | 32.7M |
| Revenue (ttm) | 3.91M |
| Net Income (ttm) | -4.47M |
| 1.05 | |
| -0.42 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.85 |
| P/S (ttm) | 8.36 |
| Earnings Date | n/a |
| Ask | 0.85 |
| Volume | 117,155 |
| Avg. Volume (20D) | 4,532,330 |
| Open | 0.84 |
| Previous Close | 0.82 |
| Day's Range | 0.82 - 0.85 |
| 52-Week Range | 0.38 - 19.19 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CPHI
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sl...
Sector Healthcare
IPO Date Apr 17, 2002
Employees 215
Stock Exchange NYSE American
Ticker Symbol CPHI
Financial Performance
In 2025, China Pharma s's revenue was 4.14M, a decrease of -8.49% compared to the previous year's 4.53M. Earnings were -3.19M, a decrease of -32.7%.
Financial StatementsEarnings Surprise
China Pharma s has released their quarterly earnings on Nov 10, 2011:
- Revenue of $948.34K misses estimates by $0, with -7.55% YoY decline.
- EPS of 40 misses estimates by -20.00, with -38.46% YoY decline.